Leon Nanodrugs

Leon Nanodrugs, founded in 2011, is a drug research and development company based on nanotechnology. The company's main product is the MicroJetRetor (MJR) technology, committed to developing enhanced versions of existing drug products and providing preclinical and clinical stage formulations for clients' NCEs or well-established branded drugs. Leon Nanodrugs offers meaningful differentiation and increased patient benefits for the next generation of nanomedicine. They specialize in using Leon's proprietary MJR® technology platform to manufacture polymer or crystalline nanoparticles to improve the bioavailability of poorly water-soluble drugs.